203 related articles for article (PubMed ID: 38931931)
1. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
Wu KY; Joly-Chevrier M; Akbar D; Tran SD
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
[TBL] [Abstract][Full Text] [Related]
3. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery.
Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Isabel Lema M; Otero-Espinar FJ
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456633
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-loaded contact lenses: eye protection against oxidative stress.
Pastori V; Tavazzi S; Lecchi M
Cornea; 2015 Jun; 34(6):693-7. PubMed ID: 25961493
[TBL] [Abstract][Full Text] [Related]
7. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes.
López-Machado A; Díaz N; Cano A; Espina M; Badía J; Baldomà L; Calpena AC; Biancardi M; Souto EB; García ML; Sánchez-López E
Int J Pharm; 2021 Nov; 609():121188. PubMed ID: 34655707
[TBL] [Abstract][Full Text] [Related]
8. Ocular drug delivery systems: An overview.
Patel A; Cholkar K; Agrahari V; Mitra AK
World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
[TBL] [Abstract][Full Text] [Related]
9. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.
Wu KY; Ashkar S; Jain S; Marchand M; Tran SD
Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987154
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Lakhani P; Patil A; Majumdar S
Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
[TBL] [Abstract][Full Text] [Related]
11. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterial-based ophthalmic drug delivery.
Xie G; Lin S; Wu F; Liu J
Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
[TBL] [Abstract][Full Text] [Related]
13. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
[TBL] [Abstract][Full Text] [Related]
14. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
Qi Q; Wei Y; Zhang X; Guan J; Mao S
J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.
Dubald M; Bourgeois S; Andrieu V; Fessi H
Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29342879
[TBL] [Abstract][Full Text] [Related]
18. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
19. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
20. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
